Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

Nature Genetics

Volumn 25, Issue 2, 2000, Pages 217-222

  Follenzi, Antonia ^a   Ailles, Laurie E ^a   Bakovic, Silvia ^a   Geuna, Massimo ^b   Naldini, Luigi ^a  

^a CANDIOLO CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GENE TRANSLOCATION; GENETIC TRANSDUCTION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; STRUCTURAL GENE; VIRUS INFECTION;

ANIMALS; BASE SEQUENCE; CELL DIVISION; CELL NUCLEUS; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; FACTOR IX; FIBROBLASTS; GENE PRODUCTS, POL; GENE TRANSFER TECHNIQUES; GENES, VIRAL; GENETIC VECTORS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HIV-1; HUMANS; LYMPHOCYTES; MACROPHAGES; MICE; MICE, SCID; MOLECULAR SEQUENCE DATA; RNA, VIRAL; TRANSDUCTION, GENETIC; VIRUS INTEGRATION;

EID: 0034040751     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/76095     Document Type: Article

References (30)

1. Naldini, L. et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267 (1996).
2. Naldini, L. Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9, 457-463 (1998).
3. Bukrinsky, M.I. et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 365, 666-669 (1993).
4. Gallay, P., Swingler, S., Aiken, C. & Trono, D. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80, 379-388 (1995).
5. Popov, S. et al. Viral protein R regulates nuclear import of the HIV-1 preintegration complex. EMBO J. 17, 909-917 (1998).
6. Charneau, P., Alizon, M. & Clavel, F. A second origin of DNA plus-strand synthesis is required for optimal human immunodeficiency virus replication. J. Virol. 66, 2814-2820 (1992).
7. Charneau, P. et al. HIV-1 reverse transcription. A termination step at the center of the genome. J. Mol. Biol. 241, 651-662 (1994).
8. Ilyinskii, P.O. & Desrosiers, R.C. Identification of a sequence element immediately upstream of the polypurine tract that is essential for replication of simian immunodeficiency virus. EMBO J. 17, 3766-3774 (1998).
9. Powell, M.D. & Levin, J.G. Sequence and structural determinants required for priming of plus-strand DNA synthesis by the human immunodeficiency virus type 1 polypurine tract. J. Virol. 70, 5288-5296 (1996).
10. Zufferey, R. et al. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880 (1998).
11. Zufferey, R., Nagy, D., Mandel, R.J., Naldini, L. & Trono, D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nature Biotechnol. 15, 871-875 (1997).
12. Dull, T. et al. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-6471 (1998).
13. Lewis, P., Hensel, M. & Emerman, M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J. 11, 3053-3058 (1992).
14. Nie, Z. et al. The putative α helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells. J. Virol. 72, 4104-4115 (1998).
15. Kiernan, R.E., Ono, A., Englund, G. & Freed, E.O. Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle. J. Virol. 72, 4116-4126 (1998).
16. Schmidtmayerova, H., Alfano, M., Nuovo, G. & Bukrinsky, M. Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4-and CXCR4-mediated pathway: replication is restricted at a postentry level. J. Virol. 72, 4633-4642 (1998).
17. Hansen, M.S. et al. Integration complexes derived from HIV vectors for rapid assays in vitro. Nature Biotechnol. 17, 578-582 (1999).
18. Miller, M.D., Farnet, C.M. & Bushman, F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 71, 5382-5390 (1997).
19. Akkina, R.K. et al. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G. J. Virol. 70, 2581-2585 (1996).
20. Case, S.S. et al. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl Acad. Sci. USA 96, 2988-2993 (1999).
21. Miyoshi, H., Smith, K.A., Mosier, D.E., Verma, I.M. & Torbett, B.E. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283, 682-686 (1999).
22. Uchida, N. et al. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl Acad. Sci. USA 95, 11939-11944 (1998).
23. Sutton, R.E., Wu, H.T., Rigg, R., Bohnlein, E. & Brown, P.O. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72, 5781-5788 (1998).
24. Conneally, E., Eaves, C.J. & Humphries, R.K. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential. Blood 91, 3487-3493 (1998).
25. Marandin, A. et al. Retrovirus-mediated gene transfer into human CD34+38low primitive cells capable of reconstituting long-term cultures in vitro and nonobese diabetic-severe combined immunodeficiency mice in vivo. Hum. Gene Ther. 9, 1497-1511 (1998).
26. Kay, M.A. & High, K. Gene therapy for the hemophilias. Proc. Natl Acad. Sci. USA 96, 9973-9975 (1999).
27. Andreadis, S.T., Brott, D., Fuller, A.O. & Palsson, B.O. Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5 to 7.5 hours. J. Virol. 71, 7541-7548 (1997).
28. Schwartz, O., Marechal, V., Friguet, B., Arenzana-Seisdedos, F & Heard, J.M. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. J. Virol. 72, 3845-3850 (1998).
29. Charneau, P. & Clavel, F. A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. J. Virol. 65, 2415-2421 (1991).
30. Bukrinskaya, A., Brichacek, B., Mann, A. & Stevenson, M. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 188, 2113-2125 (1998).